Aquestive Therapeutics: Q1 Earnings Snapshot

Published: 2026-05-13 16:11:20 ET AQST

Published on 05/13/2026 at 04:11 pm EDT

WARREN, N.J. (AP) — WARREN, N.J. (AP) — Aquestive Therapeutics Inc. (AQST) on Wednesday reported a loss of $8.1 million in its first quarter.

On a per-share basis, the Warren, New Jersey-based company said it had a loss of 7 cents.

The results exceeded Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 14 cents per share.

The specialty pharmaceutical company posted revenue of $14.4 million in the period, which also topped Street forecasts. Five analysts surveyed by Zacks expected $10.8 million.

In the final minutes of trading on Wednesday, the company's shares hit $4.11. A year ago, they were trading at $2.29.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AQST at https://www.zacks.com/ap/AQST

For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights. , source Associated Press News